← Leaderboards
Bernd G. Schnabl
Va San Diego Healthcare System
$17,461,963
Attributed
$19,579,983
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,009,420 · 15
VA$0 · 2
By mechanism
R01$10,163,774 · 3
P30$10,019,692 · 5
U01$4,143,748 · 3
R37$2,112,911 · 1
K08$707,203 · 1
R21$444,946 · 1
Top collaborators
- Lars Eckmann8 shared
- Derrick E Fouts6 shared
- David A Brenner5 shared
- Elizabeth L. Hohmann2 shared
Others in their field
Top investigators on “Liver Diseases”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Larry Arthur$49,271,333
Research focus
Liver DiseasesLiverMedicalInsightChronicBaseIntestinesDesignAffectMouse ModelLaboratoriesUnited StatesInnovationMediatingAlcoholsAlcohol AbuseAlcoholic Liver DiseasesPublicationsBacteriaHepaticMicrobiome ResearchMortalityMicrobiomeMicrobiota
Grant awards (78)
Intestinal proteases in alcohol-associated liver disease$3,182,397
R01 · FY2025 · AA · contact PI
San Diego Digestive Diseases Research Center$1,190,951
P30 · FY2025 · DK · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$499,159
R01 · FY2025 · AA · contact PI
Microbiome and Intestinal Innate Immune Response in Alcoholic Liver Disease$422,582
R37 · FY2025 · AA · contact PI
Administrative Core$233,344
P30 · FY2025 · DK · contact PI
Southern California Research Center for ALPD and Cirrhosis$230,256
P50 · FY2025 · AA · contact PI
Fecal microbiota transplantation for auto-brewery syndrome$195,906
R21 · FY2025 · AA · contact PI
Enrichment Program$37,522
P30 · FY2025 · DK · contact PI
The role of pathobionts in alcoholic liver disease$0
I01 · FY2025 · VA · contact PI
San Diego Digestive Diseases Research Center$1,205,451
P30 · FY2024 · DK · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$499,159
R01 · FY2024 · AA · contact PI
Microbiome and Intestinal Innate Immune Response in Alcoholic Liver Disease$422,582
R37 · FY2024 · AA · contact PI
Fecal microbiota transplantation for auto-brewery syndrome$249,040
R21 · FY2024 · AA · contact PI
Administrative Core$233,344
P30 · FY2024 · DK · contact PI
Southern California Research Center for ALPD and Cirrhosis$186,890
P50 · FY2024 · AA · contact PI
Enrichment Program$37,522
P30 · FY2024 · DK · contact PI
The role of pathobionts in alcoholic liver disease$0
I01 · FY2024 · VA · contact PI
San Diego Digestive Diseases Research Center$1,184,550
P30 · FY2023 · DK · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$499,298
R01 · FY2023 · AA · contact PI
Microbiome and Intestinal Innate Immune Response in Alcoholic Liver Disease$422,582
R37 · FY2023 · AA · contact PI
Administrative Core$186,412
P30 · FY2023 · DK · contact PI
Enrichment Program$24,634
P30 · FY2023 · DK · contact PI
The role of pathobionts in alcoholic liver disease$0
I01 · FY2023 · VA · contact PI
San Diego Digestive Diseases Research Center$1,184,670
P30 · FY2022 · DK · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$542,520
R01 · FY2022 · AA · contact PI
Microbiome and Intestinal Innate Immune Response in Alcoholic Liver Disease$422,582
R37 · FY2022 · AA · contact PI
Microbiome as therapeutic target in alcoholic hepatitis$301,538
U01 · FY2022 · AA · contact PI
Administrative Core$186,413
P30 · FY2022 · DK · contact PI
Enrichment Program$24,752
P30 · FY2022 · DK · contact PI
The role of Enterococcus faecalis in alcoholic liver disease$0
I01 · FY2022 · VA · contact PI
San Diego Digestive Diseases Research Center$1,184,080
P30 · FY2021 · DK · contact PI
Microbiome and Intestinal Innate Immune Response in Alcoholic Liver Disease$422,583
R37 · FY2021 · AA · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$327,904
R01 · FY2021 · AA · contact PI
Microbiome as therapeutic target in alcoholic hepatitis$301,538
U01 · FY2021 · AA · contact PI
Administrative Core$186,235
P30 · FY2021 · DK · contact PI
Human Milk Oligosaccharides for Prevention of Alcohol-Associated Liver Disease$157,750
U01 · FY2021 · AA · contact PI
Enrichment Program$24,853
P30 · FY2021 · DK · contact PI
The role of Enterococcus faecalis in alcoholic liver disease$0
I01 · FY2021 · VA · contact PI
San Diego Digestive Diseases Research Center$1,145,710
P30 · FY2020 · DK · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$348,750
R01 · FY2020 · AA · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$327,904
R01 · FY2020 · AA · contact PI
Microbiome as therapeutic target in alcoholic hepatitis$301,538
U01 · FY2020 · AA · contact PI
Administrative Core$180,247
P30 · FY2020 · DK · contact PI
San Diego Digestive Diseases Research Center$152,775
P30 · FY2020 · DK · contact PI
Enrichment Program$24,152
P30 · FY2020 · DK · contact PI
The role of Enterococcus faecalis in alcoholic liver disease$0
I01 · FY2020 · VA · contact PI
San Diego Digestive Diseases Research Center$1,181,250
P30 · FY2019 · DK · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$348,750
R01 · FY2019 · AA · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$327,904
R01 · FY2019 · AA · contact PI
Microbiome as therapeutic target in alcoholic hepatitis$305,515
U01 · FY2019 · AA · contact PI
Administrative Core$185,822
P30 · FY2019 · DK · contact PI
Enrichment Program$25,003
P30 · FY2019 · DK · contact PI
The role of Enterococcus faecalis in alcoholic liver disease$0
I01 · FY2019 · VA · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$348,750
R01 · FY2018 · AA · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$327,904
R01 · FY2018 · AA · contact PI
Microbiome as therapeutic target in alcoholic hepatitis$309,999
U01 · FY2018 · AA · contact PI
The Commensal Microflora Suppresses Liver Fibrosis$0
I01 · FY2018 · VA · contact PI
Microbiome as Therapeutic Target in Alcoholic Hepatitis$427,499
U01 · FY2017 · AA · contact PI
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease$352,654
U01 · FY2017 · AA · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$348,750
R01 · FY2017 · AA · contact PI
The Commensal Microflora Suppresses Liver Fibrosis$0
I01 · FY2017 · VA · contact PI
Microbiome as Therapeutic Target in Alcoholic Hepatitis$427,498
U01 · FY2016 · AA · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$348,750
R01 · FY2016 · AA · contact PI
The Commensal Microflora Suppresses Liver Fibrosis$0
I01 · FY2016 · VA · contact PI
Microbiome as Therapeutic Target in Alcoholic Hepatitis$414,673
U01 · FY2015 · AA · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$375,875
R01 · FY2015 · AA · contact PI
The Commensal Microflora Suppresses Liver Fibrosis$0
I01 · FY2015 · VA · contact PI
Microbiome as Therapeutic Target in Alcoholic Hepatitis$414,673
U01 · FY2014 · AA · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$375,875
R01 · FY2014 · AA · contact PI
Microbiome as Therapeutic Target in Alcoholic Hepatitis$428,873
U01 · FY2013 · AA · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$360,375
R01 · FY2013 · AA · contact PI
Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosis$143,456
K08 · FY2013 · DK · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$387,500
R01 · FY2012 · AA · contact PI
Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosis$143,456
K08 · FY2012 · DK · contact PI
Microbiome and intestinal innate immune response in alcoholic liver disease$386,250
R01 · FY2011 · AA · contact PI
Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosis$143,456
K08 · FY2011 · DK · contact PI
Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosis$140,064
K08 · FY2010 · DK · contact PI
Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosis$136,771
K08 · FY2009 · DK · contact PI